01.07.2021 • News

Solvay Appoints Pascal Chalvon Demersay as Chief Sustainability and Government Affairs Officer

Solvay has appointed Pascal Chalvon Demersay to chief sustainability and government affairs officer, effective July 1, 2021, integrating the new responsibilities to his current role as chief sustainability officer.

Solvay said that Chalvon Demersay was the architect and an instrumental driving force behind the company’s 2030 sustainability program, Solvay One Planet.

Chalvon Demersay assumes responsibility for government affairs from Alexis Brouhns, previously head of government and public affairs, who retires after more than 16 years with Solvay.

Chalvon Demersay graduated from the Ecole Polytechnique de Paris. He started his career in 1990 as a site manager and held several management positions on different continents. In 2007, he joined Bluestar Silicones, which integrated the Solvay group’s former silicones activity, and became their CEO in 2010. In July 2015, he was appointed president of Solvay Energy Services and later became Solvay's chief sustainability officer in 2016.

Solvay has appointed Pascal Chalvon Demersay to chief sustainability and...
Solvay has appointed Pascal Chalvon Demersay to chief sustainability and government affairs officer, effective July 1, 2021. © Solvay

Company

Logo:

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read